 Matinas BioPharma Holdings Inc. NYSE:MTNB Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Jerome Jabbour - Chief Executive Officer Theresa Matkovits - Chief Development Officer Terry Ferguson - Chief Medical Officer Keith Kucinski - Chief Financial Officer Peter Vozzo - Investor Relations Conference Call Participants Bert Hazlett - BTIG Operator Welcome to the Matinas BioPharma first quarter 2022 results conference call. At this time, all participants are in a listen-only mode. 